Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, June 20, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Anthony Petrone Maintained (ADMA) at Strong Buy with Increased Target to $14 on, Jun 20th, 2024
Anthony Petrone of Mizuho, Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Increased Target from $12 to $14 on, Jun 20th, 2024.
Anthony has made no other calls on ADMA in the last 4 months.
There are 3 other peers that have a rating on ADMA. Out of the 3 peers that are also analyzing ADMA, 0 agree with Anthony's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Anthony
- Elliot Wilbur of "Raymond James" Maintained at Strong Buy with Increased Target to $10 on, Friday, May 10th, 2024
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $10 on, Friday, May 10th, 2024
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $10 on, Friday, May 10th, 2024
